Addex Therapeutics Ltd (0QNV)
LSE
Closed
Sep 18, 2026
Day's Range
0.024452 wk Range
0.0232Overview - 0QNV - Addex Therapeutics Ltd
Key Statistics
Valuation
Enterprise Value
3.56M
P/E (Trailing)
‪0.40‬
Price / Sales (TTM)
‪0.01‬
Price / Book
‪2.21‬
EV / EBITDA
‪-1.37‬
Profitability
Gross Margin
‪40.59%‬
Profit Margin
‪48.34%‬
Operating Margin
‪-6,487.25%‬
Return on Assets
‪-27.11%‬
Return on Equity
‪-150.57%‬
Ownership
Shares Outstanding
26.37M
Float
141.92M
Held by Insiders
‪9.99%‬
Held by Institutions
‪1.04%‬
Price stats
50-Day Avg
‪0.0628‬
200-Day Avg
‪0.0628‬
Market Cap - 0QNV - Addex Therapeutics Ltd
Peers - 0QNV - Addex Therapeutics Ltd
Peer Comparison
Compared with companies in Biotechnology listed on LSE.
- 0QNVLSEAddex Therapeutics Ltd643.47KMarket Cap-141.80%52-week change0.41P/E (Trailing)‪48.34%‬Profit Margin
- 0MGBLSEGenmab A/S198.39BMarket Cap+15.12%52-week change33.69P/E (Trailing)‪29.01%‬Profit Margin
- 0QZULSEVertex Pharmaceuticals Incorporated Common Stock128.96BMarket Cap+20.00%52-week change0.53P/E (Trailing)‪34.99%‬Profit Margin
- 0A45LSEModerna Inc.95.05BMarket Cap+87.31%52-week change72.95P/E (Trailing)‪11.32%‬Profit Margin
- 0R2MLSERegeneron Pharmaceuticals, Inc.79.08BMarket Cap+20.99%52-week change0.11P/E (Trailing)‪27.86%‬Profit Margin
- 0QW0LSEargenx SE49.68BMarket Cap+27.60%52-week change40.07P/E (Trailing)‪-47.51%‬Profit Margin
- 0NZTLSEUCB SA41.70BMarket Cap-23.88%52-week change120.47P/E (Trailing)‪6.45%‬Profit Margin
Profile Summary - 0QNV - Addex Therapeutics Ltd
About
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company headquartered in Geneva, Switzerland, specializing in the development of novel small molecule allosteric modulators for neurological disorders. These orally available drugs target receptors to offer potential therapeutic advantages over conventional…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
